<!DOCTYPE html>
<html lang = "en">


<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />


  
  <!-- fetch the title & body fonts immediately to avoid re-rendering -->

  <link rel="preload" as="style"      href="/static/css/default.css" />
  <link rel="preload" href="/static/font/ssfp/SourceSerifPro-BASIC-Regular.ttf"        as="font" type="font/ttf" crossorigin="anonymous">
  <link rel="preload" href="/static/font/ssfp/SourceSerifPro-BASIC-Semibold.ttf"       as="font" type="font/ttf" crossorigin="anonymous">
  <link rel="preload" href="/static/font/ssfp/SourceSerifPro-BASIC-RegularItalic.ttf"  as="font" type="font/ttf" crossorigin="anonymous">

<style>
  @font-face {
      font-family: 'Source Serif Pro';
      font-weight: 400;
      font-style: normal;
      src: url('/font/ssfp/SourceSerif4-Regular.ttf.woff') format('woff');
      src: url('/static/font/ssfp/SourceSerifPro-BASIC-Regular.ttf') format('truetype');
      unicode-range: U+0020-007E, U+2010, U+2013-2014, U+2018-2019, U+201C-201D;
      font-display: swap
  }
  @font-face {
      font-family: 'Source Serif Pro';
      font-weight: 400;
      font-style: italic;
      src: url('/font/ssfp/SourceSerif4-It.ttf.woff') format('woff');
      src: url('/static/font/ssfp/SourceSerifPro-BASIC-RegularItalic.ttf') format('truetype');
      unicode-range: U+0020-007E, U+2010, U+2013-2014, U+2018-2019, U+201C-201D;
      font-display: swap;
  }
  @font-face {
      font-family: 'Source Serif Pro';
      font-weight: 600;
      font-style: normal;
      src: url('/font/ssfp/SourceSerif4-SemiboldIt.ttf.woff') format('woff');
      src: url('/static/font/ssfp/SourceSerifPro-BASIC-Semibold.ttf') format('truetype');
      unicode-range: U+0020-007E, U+2010, U+2013-2014, U+2018-2019, U+201C-201D;
      font-display: swap
  }


  </style>
 

  <meta name="author" content="James Maye" />
  <meta name="title" content="Haematological Malignancy">
  <meta name="generator" content="Pandoc">

  <link rel="stylesheet" type="text/css" href="/static/css/default.css" />
  <link rel="icon" type="image/png" href="/static/img/m.png" />
  
  <title>Haematological Malignancy Â· James Maye</title>


</head>



<body>
    <main>
       
<!-- Navbar Goes here -->
        <div id="nav">

            <div id="navbar">

                <div>
                    <a href="/medicine">Medicine</a>
                </div>

                <div>
                    <a href="/">JM</a>
                </div>

                <div>
                    <a href="">Chapter</a>
                </div>


                </div>
            </div> 
<!-- End navbar -->
    	

     <header id="top">
         <h1>Haematological Malignancy</h1>
     </header>

     <article>
<!-- Top matter start -->
         <div id="page-metadata">
             <p>
                 <span id="page-description" title="Short summary of article."><em>Cancers arising from bone marrow stem cells, historically divided into leukaemias and lymphomas.</em></span>
                 <br/>
                 <span id="tags" title="Tags list"><em>
                     <a href="/tags/medicine">medicine</a>, <a href="/tags/haematology">haematology</a>, <a href="/tags/cancer">cancer</a>
                 </em></span>
                 <br/>
                 <span id="page-metadata-block">
                     
                     <!-- Date created - date modified -->
                     <span id="page-date-range"><span id="page-creation" title="Date page contents were begun."><em>20/02/2021</em></span> &ndash;  <!--endash with space either side--><span id="page-source"><a title="Link to latest revision of the raw Markdown text source for this page, 'Haematological Malignancy': haematological-malignancy.md" href="haematological-malignancy.md"><span id="page-modified" title="Date of last major modification to this page."><em>05/03/2021</em></span></a></span></span>
                     
                     <span id="page-status" title="Status of current page: 'abandoned/notes/in progress/finished'"><em>notes</em></span>
                </span> <!-- page-metadata-block end-->     
             </p>
             <hr>
         
         </div> <!-- page-metadata end -->
<!-- Top matter end -->
         <div id="md-body">
    
<p>Haematological malignancies are cancers arising from the bone marrow precursor cells. One way of thinking about them is to divide them into four broad categories:</p>
<ul>
<li>Leukaemias</li>
<li>Lymphomas</li>
<li>Myelodysplasias</li>
<li>Myeloproliferative disorders</li>
</ul>
<p>Acute leukaemias are characterised by excess primitive blast cells within the bone marrow, spilling out into the blood. Chronic leukaemias, in contrast, have an excess of more mature blood cells in the marrow and blood. In lymphomas, malignant cells generally are found within the lymph nodes, spleen and thymus rather than the bone marrow. This is a relatively arbitrary distinction however and there is significant overlap between lymphomas and leukaemias. For this reason, some argue to do away with the distinction and instead think about haematological malignancies as either of lymphoid origin or myeloid origin.</p>
<h2 id="leukaemias">Leukaemias</h2>
<ul>
<li>Acute leukaemias
<ul>
<li><span class="JM-link"><a href="acute-lymphoblastic-leukaemia">Acute Lymphoblastic Leukaemia</a></span> (ALL)</li>
<li><span class="JM-link"><a href="acute-myeloid-leukaemia">Acute Myeloid Leukaemia</a></span> (AML)</li>
</ul></li>
<li>Chronic leukaemias
<ul>
<li><span class="JM-link"><a href="chronic-lymphoblastic-leukaemia">Chronic Lymphoblastic Leukaemia</a></span> (CLL)</li>
<li><span class="JM-link"><a href="chronic-myeloid-leukaemia">Chronic Myeloid Leukaemia</a></span> (CML)</li>
</ul></li>
</ul>
<h3 id="acute-leukaemias">Acute Leukaemias</h3>
<p>Acute leukaemias are characterised by an excess (&gt;5%) of primitive blast cells within the marrow.</p>
<p><span class="JM-link"><a href="acute-lymphoblastic-leukaemia">Acute Lymphoblastic Leukaemia</a></span> (ALL), is a high-grade haematological malignancy. It is the commonest form of cancer in children. Central nervous system involvement is common, requiring prophylactic intrathecal cytotoxic therapy. It is generally curable, with a cure rate of greater than 80% with chemotherapy. ALL is further subclassified based upon immunohistochemistry.</p>
<p><span class="JM-link"><a href="acute-myeloid-leukaemia">Acute Myeloid Leukaemia</a></span>, in contrast, predominantly affects adults. It usually requries myelosuppressive chemotherapy in order to reduce remission, although the cure rate is lower than ALL at only ~30%. CNS involvement is rare. It is generally characterised on morphological characteristics (the M0-M7 system).</p>

         </div> <!-- div id="md-body" -->
    </article>

</main>
</body>
</html>


